Thanks for the reply. I think all analysis and forecasts should be taken lightly. At 40m MC we are well and truly in the 'speculative' category. And by assumption speculation assumes the massive amount of unknowns (read risk). If anyone is taking a pie in the sky estimates on HC to make their investment decisions they should get their heads checked. Given its a highly speculative play, it assumes valuations and investing is done on exactly that, speculation.
Now, I'm not sure on where you got your figures, but the article you quote suggests WRIST-wearables were 34m in Q2 2019 up 28% from the prior year. Extrapolating that out you get 136m wrist-wearable devices sold internationally. I suggested 60m for China. Am I missing something?
Also, I was quoting the Chinese market. See here for the article. Although it doesn't state 60% wrist wearables, the biggest seller (Xiaomi) in the market sold circa 9.4m wrist-wearable devices in Q4 2019 so which represented 73% of their total sales. China also accounted for more than 20% of Apple Watch sales, which equates to around 6 million units. So we are only off about 4 million wrist wearables, which I graciously appropriated to the rest of the market. Keeping in mind Apple runs third in China.
Also see here article (published in June 2019, so a bit old) suggesting smartwatches being the fasting growing market for wearables in China.
In any case, as stated above the point of my post was to wrap some loose figures around the types of markets we operate in. The hope is that we get a healthy amount of healthy input or thoughts from other posters to bridge the asymmetries in information about the unknown potential of our little stock here.
IMO DYOR
- Forums
- ASX - By Stock
- Technical 200dma bullish cross
CDX
cardiex limited
Add to My Watchlist
0.00%
!
4.0¢

Thanks for the reply. I think all analysis and forecasts should...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
4.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $17.94M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 49999 | 3.9¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
4.2¢ | 60000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 49999 | 0.039 |
3 | 340000 | 0.038 |
4 | 657100 | 0.037 |
2 | 263210 | 0.036 |
3 | 365503 | 0.035 |
Price($) | Vol. | No. |
---|---|---|
0.042 | 60000 | 1 |
0.045 | 202414 | 3 |
0.050 | 100000 | 1 |
0.052 | 180000 | 1 |
0.080 | 100799 | 1 |
Last trade - 16.21pm 26/06/2025 (20 minute delay) ? |
Featured News
CDX (ASX) Chart |
Day chart unavailable
The Watchlist
PTX
PRESCIENT THERAPEUTICS LIMITED
James McDonnell, CEO
James McDonnell
CEO
Previous Video
Next Video
SPONSORED BY The Market Online